We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.


Clear all

Refine your search

Content type




458 results found


Addisons | Australia | 5 Jun 2019

Permitted Indications in respect of Listed Complementary Medicines in Australia

As we reported in October 2018, significant legislative changes have been made to the Therapeutic Goods Act 1989 (TG Act) in respect of the


Addisons | Australia | 4 Jun 2019

Your crypto decrypt: ASIC updates guidance on ICOs and crypto-assets

The Australian Securities & Investments Commission (ASIC) has updated its guidance about the regulatory regimes that may apply to initial coin


Addisons | Australia | 30 May 2019

Know the difference between 'general advice' and 'personal advice': ASIC v Westpac Securities Administration Ltd

It is very important for Australian Financial Services (AFS) licensees to know the difference between general advice and personal advice to make sure


Addisons | Australia | 30 May 2019

Proposed Reform to ASX Listing Rules Deferred to 1 December 2019

In the January 2019 edition of our ECM Bulletin, we reported on a series of major reforms that ASX is proposing to make to its listing rules, with


Addisons | Australia | 27 May 2019

Update on the two 'explosive cases' arising from ANZ's 2015 $2.5 billion placement

In September last year, the AFR reported that two “explosive cases have upended capital markets, with investment banks' compliance and deal teams


Addisons | Australia | 20 May 2019

Unilever all in a sweat over new player's 'clinical' efficacy claims

The Federal Court recently examined whether representations alleged by Unilever to have been made by Beiersdorf about Beiersdorf’s Nivea ‘Stress


Addisons | Australia | 15 May 2019

Time to Whet your Whistle

Sailing through parliament, the impending whistleblower amendments are due to commence on 1 July 2019. But stormy seas abound for public and large


Addisons | Australia | 14 May 2019

Equity derivative positions back on the table - do you need to disclose your holdings? The Takeovers Panel considers revising its Guidance Note 20 on disclosure of equity derivatives

Back in 2012, we discussed issues around disclosure of equity derivatives in our paper, “Laying Your Cards on the Table - Equity Derivative Positions


Addisons | Australia | 13 May 2019

Director's duties: responding to corporate opportunity and shareholder activism

One unlisted Australian public company, CellOS Software Ltd (CellOS), has been spending much time before the Federal Court lately, in one case


Addisons | Australia | 9 May 2019

Addisons Contractual Interpretation Series - Taking advantage of your own wrong

This is one of a series of articles in which we consider issues relevant to the interpretation of contracts. In this article we look at the rule of

Previous page 1 2 3 ...